Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Miriam Fuchs is active.

Publication


Featured researches published by Miriam Fuchs.


Cell | 1998

Gene Dosage–Dependent Embryonic Development and Proliferation Defects in Mice Lacking the Transcriptional Integrator p300

Tso-Pang Yao; Suk Paul Oh; Miriam Fuchs; Nai-Dong Zhou; Lian-Ee Ch'ng; David Newsome; Roderick T. Bronson; En Li; David M. Livingston; Richard Eckner

The transcriptional coactivator and integrator p300 and its closely related family member CBP mediate multiple, signal-dependent transcriptional events. We have generated mice lacking a functional p300 gene. Animals nullizygous for p300 died between days 9 and 11.5 of gestation, exhibiting defects in neurulation, cell proliferation, and heart development. Cells derived from p300-deficient embryos displayed specific transcriptional defects and proliferated poorly. Surprisingly, p300 heterozygotes also manifested considerable embryonic lethality. Moreover, double heterozygosity for p300 and cbp was invariably associated with embryonic death. Thus, mouse development is exquisitely sensitive to the overall gene dosage of p300 and cbp. Our results provide genetic evidence that a coactivator endowed with histone acetyltransferase activity is essential for mammalian cell proliferation and development.


EMBO Reports | 2003

MYC recruits the TIP60 histone acetyltransferase complex to chromatin

Scott R. Frank; Tiziana Parisi; Stefan Taubert; Paula C. Fernandez; Miriam Fuchs; Ho Man Chan; David M. Livingston; Bruno Amati

The transcription factor MYC binds specific DNA sites in cellular chromatin and induces the acetylation of histones H3 and H4. However, the histone acetyltransferases (HATs) that are responsible for these modifications have not yet been identified. MYC associates with TRRAP, a subunit of distinct macromolecular complexes that contain the HATs GCN5/PCAF or TIP60. Although the association of MYC with GCN5 has been shown, its interaction with TIP60 has never been analysed. Here, we show that MYC associates with TIP60 and recruits it to chromatin in vivo with four other components of the TIP60 complex: TRRAP, p400, TIP48 and TIP49. Overexpression of enzymatically inactive TIP60 delays the MYC‐induced acetylation of histone H4, and also reduces the level of MYC binding to chromatin. Thus, the TIP60 HAT complex is recruited to MYC‐target genes and, probably with other other HATs, contributes to histone acetylation in response to mitogenic signals.


Cell | 2001

The p400 complex is an essential E1A transformation target.

Miriam Fuchs; Jill Gerber; Ronny Drapkin; Saïd Sif; Tsuyoshi Ikura; Vasily V. Ogryzko; William S. Lane; Yoshihiro Nakatani; David M. Livingston

Here, we report the identification of a new E1A binding protein complex that is essential for E1A-mediated transformation. Its core component is a SWI2/SNF2-related, 400 kDa protein (p400). Other components include the myc- and p/CAF-associated cofactor, TRRAP/PAF400, the DNA helicases TAP54alpha/beta, actin-like proteins, and the human homolog of the Drosophila Enhancer of Polycomb protein. An E1A mutant, defective in p400 binding, is also defective in transformation. Certain p400 fragments partially rescued this phenotype, underscoring the role of E1A-p400 complex formation in the E1A transforming process. Furthermore, E1A and c-myc each alter the subunit composition of p400 complexes, implying that physiological p400 complex formation contributes to transformation suppression.


Molecular and Cellular Biology | 2004

E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1.

Stefan Taubert; Chiara Gorrini; Scott R. Frank; Tiziana Parisi; Miriam Fuchs; Ho Man Chan; David M. Livingston; Bruno Amati

ABSTRACT E2F proteins can either activate or repress transcription. Following mitogenic stimulation, repressive E2F4-p130-histone deacetylase complexes dissociate from, while activating species (E2F1, -2, and -3) associate with, target promoters. Histones H3 and H4 simultaneously become hyperacetylated, but it remains unclear whether this is a prerequisite or a consequence of E2F binding. Here, we show that activating E2F species are required for hyperacetylation of target chromatin in human cells. Overexpression of a dominant-negative (DN) E2F1 mutant in serum-stimulated T98G cells blocked all E2F binding, H4 acetylation, and, albeit partially, H3 acetylation. Target gene activation and S-phase entry were also blocked by DN E2F1. Conversely, ectopic activation of E2F1 rapidly induced H3 and H4 acetylation, demonstrating a direct role for E2F in these events. E2F1 was previously shown to bind the histone acetyltransferases (HATs) p300/CBP and PCAF/GCN5. In our hands, ectopically expressed E2F1 also bound the unrelated HAT Tip60 and induced recruitment of five subunits of the Tip60 complex (Tip60, TRRAP, p400, Tip48, and Tip49) to target promoters in vivo. Moreover, E2F-dependent recruitment of Tip60 to chromatin occurred in late G1 following serum stimulation. We speculate that the activities of multiple HAT complexes account for E2F-dependent acetylation, transcription, and S-phase entry.


EMBO Reports | 2002

Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6

Jörg Storre; Hans-Peter Elsässer; Miriam Fuchs; Diana Ullmann; David M. Livingston; Stefan Gaubatz

E2F transcription factors play an important role in regulating mammalian cell proliferation. E2F6, the most recently identified E2F family member, is a transcriptional repressor. In an effort to ascertain the in vivo biological function of E2F6, we have generated an E2f6 mutant mouse strain. Mice lacking E2F6 are viable and healthy. Surprisingly, E2f6−/− embryonic fibroblasts proliferate normally. However, E2f6−/− animals display overt homeotic transformations of the axial skeleton that are strikingly similar to the skeletal transformations observed in polycomb mutant mice. This observation is compatible with the recent finding that endogenous E2F6 and one or more mammalian polycomb proteins are components of the same multiprotein complex. The accumulated evidence suggests that, during development, E2F6 participates in the recruitment of polycomb proteins to specific target promoters.


Mechanisms of Development | 1996

Isolation and developmental expression analysis of Enx-1, a novel mouse Polycomb group gene.

Oliver Hobert; Irmi Sures; Thomas Ciossek; Miriam Fuchs; Axel Ullrich

Members of the Polycomb group (Pc-G) of genes encode transcriptional regulators that control the expression of key developmental effector genes in Drosophila melanogaster. Although multiple Pc-G genes have been identified and characterized in Drosophila, information about these important regulatory proteins in vertebrates, including their precise expression patterns, has remained scarce. We report here the cloning of Enx-1, a novel vertebrate Pc-G gene, which encodes the murine homolog of the Drosophila Enhancer of zeste (E(z)) gene. Drosophila E(z) controls the expression of several homeobox genes as well as some segmentation genes and its disruption causes multiple phenotypes in Drosophila development. Analysis of the primary structure of murine Enx-1 reveals the conservation of several regions, including the previously described SET domain and a newly defined CXC domain. In addition, we find the SET domain to be conserved in evolutionarily distant species ranging from vertebrates to plants and fungi. The expression pattern analysis of Enx-1 reveals ubiquitous expression throughout early embryogenesis, while in later embryonic development Enx-1 expression becomes restricted to specific sites within the central and peripheral nervous system and to the major sites of fetal hematopoiesis. In adult stages we also find Enx-1 expression to be restricted to specific tissues, including spleen, testis and placenta.


Mechanisms of Development | 1998

Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development

Miriam Fuchs; Hongyang Wang; Thomas Ciossek; Zhengjun Chen; Axel Ullrich

The MAM-subfamily of type II transmembrane protein tyrosine phosphatases (PTPases) currently comprises the enzymes PTPkappa, PTPmu and PCP2. In an effort to elucidate the individual physiological roles of these closely related proteins we performed a detailed analysis of their mRNA transcript distributions at different stages of mouse embryogenesis and postnatal brain development. Our in situ hybridization studies revealed distinct and complementary expression patterns of PTPkappa, PTPmu and PCP2 transcripts. Based on our results and previous reports we discuss MAM-PTPases as a new class of morphoregulatory molecules.


Journal of Biological Chemistry | 1996

Association of human protein-tyrosine phosphatase kappa with members of the armadillo family.

Miriam Fuchs; Thomas Müller; Markus M. Lerch; Axel Ullrich


Journal of Biological Chemistry | 2005

p400 Is Required for E1A to Promote Apoptosis

Andrew V. Samuelson; Masako Narita; Ho Man Chan; Jianping Jin; Elisa de Stanchina; Mila E. McCurrach; Masashi Narita; Miriam Fuchs; David M. Livingston; Scott W. Lowe


Archive | 1994

Nouvelle phosphotyrosine phosphatase-kappa de type recepteur

Joseph Schlessinger; Jan Sap; Axel Ullrich; Wolfgang F. Vogel; Miriam Fuchs

Collaboration


Dive into the Miriam Fuchs's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Axel Ullrich

University of California

View shared research outputs
Top Co-Authors

Avatar

Stefan Taubert

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno Amati

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Axel Ullrich

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tiziana Parisi

Massachusetts Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge